Action profiles of predictors of death and survival time in stage I malignant melanoma

Developmental Neuroscience

Volumn 192, Issue 1, 1996, Pages 1-7

  Helfenstein, U ^a   Schuler G ^a,b   Morf, S ^a   Schuller D ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

AMPA receptors; Developing rat brain; Epilepsy; GABAA receptors; Gene expression; Hybridization in situ; Kainic acid; NMDA receptors; Seizures; Silver impregnation

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE REGRESSION; NONLINEAR SYSTEM; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL MODEL; SURVIVAL TIME; SYSTEM ANALYSIS; TUMOR VOLUME;

EID: 0030047375     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000246303     Document Type: Article

References (19)

1. Cascinclli N. Marubini E. Morabilo A. Bufa-lino R: Prognostic factors for stage I melanoma of the skin: A review. Slat Med 1985:4: 265-278.
2. Vollmcr RT: Malignant melanoma, a multivariate analysis of prognostic factors. Pathol Annu 1989:24:383-407
3. Balch CM. Cascinclli N. Drzewiecki KT: A comparison of prognostic factors worldwide: in Balch CM. Houghton AN (eds): Cutaneous Melanoma, ed 2. Philadelphia. Lippincolt, 1992. pp 188-199.
4. Vossaerl KA. Silverman MK. Kopf AW. Bart RS. Rigel DS. Friedman R.I. Levenslein M: Influence of gender on survival of patients with stage I malignant melanoma. J Am Acad Dermatol 1992;26:429-440.
5. Hastie T. Tibshirani R: Generalized additive models: Some applications. J Am Stat Assoc 1987:82:371-386.
6. Hastie T. Tibshirani R: Generalized Additive Models. London. Chapman and Hall, 1990.
7. Hastie T. Sleeper L. Tibshirani R: Flexible covariate effects in the proportional hazards model. Breast Cancer Res Treat 1992:22: 241-250.
8. Harrell FE. Lee KL. Pollock BG: Regression models in clinical studies: Determining relationships between predictors and response. J Natl Cancer Inst 1988:80:1198-1202.
9. Durrlcman S. Simon R: Flexible regression models with cubic splines. Stat Med 1989:8: 551-561.
10. Tillman DM. Aitchison T. Wall DC. MacKie RM: Stage II melanoma in the west of Scotland. 1976-1985: Prognostic factors for survival. Eur J Cancer 1991;27:870-876.
11. MacKie RM. Aitchison T. Sirei JM. McLaren K. Watt DC: Prognostic models for subgroups of melanoma patients from the Scottish melanoma group data base 1979-86. And their subsequent validation. Br J Cancer 1995:71: 173-176.
12. Keefe M. MacKie RM: The relationship between risk of death from clinical stage I cutaneous melanoma and thickness of primary tumor: No evidence for steps in risk. Br J Cancer 1991;64:598-602.
13. Efron B. Tibshirani R: A Introduction to the Bootstrap. London. Chapman and Hall. 1993.
14. Simon R. Altman DG: Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994:69:979-985.
15. StatSci: S-Plus. Reference Manual. Seattle. Statistical Sciences Inc. 1991.
16. Almudevar T. Tibshirani R: GAIM Users Guide. Toronto. Tibshirani Enterprises Inc. 1991.
17. Thorn M. Ponten F. Bergstrom R. Sparen P. Adami O: Clinical and histopathological predictors of survival in patients with malignant melanoma: A population-based study in Sweden. J Natl Cancer Inst 1994:86:761-769.
18. Cascinelli N. Morabito A. Bufalino R. van der Esch EP. Preda F. Vaglini M. Rovini D. Orefice S: Prognosis of stage I melanoma of the skin. Int J Cancer 1980:26:733-739.
19. Sober AJ. Day CL. Fitzpatrick TB. Lew RA. Kopf AW. Milan MC: Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage 1 patients. J Invest Dermatol 1983:80:53s-55s.